Early research (Phase 1)Ended earlyNCT00006222What this trial is testingEMD 121974 in Treating Patients With HIV-Related Kaposi's SarcomaWho this might be right forSarcoma National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00000725What this trial is testingA Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 56
Not applicableStudy completedNCT00075777What this trial is testingValproic Acid in Treating Patients With Kaposi's SarcomaWho this might be right forSarcoma AIDS Malignancy Consortium 19
Testing effectiveness (Phase 2)Study completedNCT00020449What this trial is testingLiposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's SarcomaWho this might be right forSarcoma National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00002212What this trial is testingTargretin Capsules in Patients With AIDS-Related Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections Ligand Pharmaceuticals 27
Large-scale testing (Phase 3)UnknownNCT00002318What this trial is testingA Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections Sequus Pharmaceuticals 225
Testing effectiveness (Phase 2)Study completedNCT01057121What this trial is testingLenalidomide in Treating Patients With AIDS-Associated Kaposi's SarcomaWho this might be right forAIDS-Related Kaposi SarcomaRecurrent Kaposi Sarcoma National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Study completedNCT00000687What this trial is testingPhase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT01016730What this trial is testingBortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi SarcomaWho this might be right forAIDS-Related Kaposi SarcomaHIV InfectionRecurrent Kaposi Sarcoma National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00002188What this trial is testingALRT1057 in Patients With AIDS-Related Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections Anderson Clinical Research 27
Post-approval studies (Phase 4)Study completedNCT00444379What this trial is testingAnti-Retrovirals for Kaposi's SarcomaWho this might be right forKaposi's SarcomaHIV Infections University of California, San Francisco 224
Early research (Phase 1)Study completedNCT05567601What this trial is testingDoxil/Caelyx BE StudyWho this might be right forOvarian CancerAIDS-related Kaposi SarcomaMultiple Myeloma+1 more Baxter Healthcare Corporation 36
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Early research (Phase 1)Ended earlyNCT04893018What this trial is testingNT-I7 for Kaposi Sarcoma in Patients With or Without HIVWho this might be right forAIDS-Related Kaposi SarcomaHIV InfectionKaposi Sarcoma Fred Hutchinson Cancer Center 8
Testing effectiveness (Phase 2)WithdrawnNCT00521092What this trial is testingSunitinib Malate in Treating East African Patients With Kaposi SarcomaWho this might be right forAIDS-related Kaposi SarcomaClassic Kaposi Sarcoma National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00005931What this trial is testingSU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to TreatmentWho this might be right forSarcoma, KaposiHIV Infections SUGEN 30
Early research (Phase 1)Study completedNCT00000954What this trial is testingChemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 72
Testing effectiveness (Phase 2)Study completedNCT00055237What this trial is testingBevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative PatientsWho this might be right forKaposi's SarcomaHIV InfectionsHIV Seronegativity National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)Not Yet RecruitingNCT05411237What this trial is testingPaclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi SarcomaWho this might be right forKaposi SarcomaHIV-1-infectionAIDS-related Kaposi Sarcoma AIDS Malignancy Consortium 130
Large-scale testing (Phase 3)Study completedNCT00002105What this trial is testingRandomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections Sequus Pharmaceuticals 220